It is unclear whether there will also be testing in larger cities. ...
Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older — ...
The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.
Meanwhile, COVID activity remained low amid a shift in variant proportions and RSV levels rose in 3 US regions.
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Moderna (MRNA) announced Health Canada has approved mRESVIA for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in adults 60 years of ...
WILKES-BARRE— The Pennsylvania Department of Aging (PDA) this week hosted its 2024 Alzheimer’s Disease and Related Disorders ...